NVAX Insider Trading
Insider Ownership Percentage: 1.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $985,852.80
Novavax Share Price & Price History
Current Price: $6.14
Price Change: ▲ Price Increase of +0.14 (2.33%)
As of 04/2/2025 03:46 PM ET
Novavax Insider Trading History
Novavax Institutional Trading History
Data available starting January 2016
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Read More on Novavax
Volume
7,620,206 shs
Average Volume
8,028,806 shs
Market Capitalization
$987.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.92
Who are the company insiders with the largest holdings of Novavax?